Brief

Google DeepMind's Co-Scientist AI has identified promising drug candidates for liver fibrosis, a condition causing over 1.4 million deaths annually. In lab tests using human liver cells, two of the three drugs suggested by Co-Scientist effectively blocked fibrosis and promoted cell regeneration. Notably, the cancer drug vorinostat, identified by Co-Scientist, blocked 91% of a damage response linked to liver scarring, suggesting a new generation of anti-fibrotic medicines. AI